Therapeutic inhibitor of vascular smooth muscle cells

  • US 6,599,928 B2
  • Filed: 07/20/2001
  • Issued: 07/29/2003
  • Est. Priority Date: 09/25/1992
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method for maintaining vessel luminal area, comprising inserting into a mammalian vessel an intravascular stent comprising a cytostatic agent that does not exhibit substantial cytotoxicity in an amount which allows for vascular repair and extracellular matrix production and reduces stenosis or restenosis upon placement of the stent.

View all claims

    Thank you for your feedback